Prednisolone does not improve olfactory function after COVID-19: a randomized, double-blind, placebo-controlled trial

Abstract Background Prednisolone has been suggested as a treatment for olfactory disorders after COVID-19, but evidence is scarce. Hence, we aimed to determine the efficacy of a short oral prednisolone treatment on patients with persistent olfactory disorders after COVID-19. Methods We performed a r...

Full description

Bibliographic Details
Main Authors: Emma J. A. Schepens, Esther E. Blijleven, Wilbert M. Boek, Sanne Boesveldt, Robert J. Stokroos, Inge Stegeman, Digna M. A. Kamalski
Format: Article
Language:English
Published: BMC 2022-11-01
Series:BMC Medicine
Subjects:
Online Access:https://doi.org/10.1186/s12916-022-02625-5